Minimal deletion of 3p13→14.2 associated with immortalization of human uroepithelial cells
✍ Scribed by Lydia Vieten; Cassandra D. Belair; Lena Savelieva; Knut Jülicher; Frank Bröcker; Walter Bardenheuer; Jochen Schütte; Bertram Opalka; Catherine A. Reznikoff
- Book ID
- 101260895
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 262 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Immortalization and tumorigenic transformation of many human cell types, including human uroepithelial cells (HUCs), are frequently associated with loss of genetic material from the short arm of chromosome 3 (3p). In addition, losses of 3p have been observed in many human cancers including renal cell carcinoma, lung cancer, breast cancer, and bladder cancer. Genetic studies suggest that there are at least two regions on 3p in which tumor suppressor genes might be located, but the precise location of these genes is not known. We studied chromosome 3 losses that were specifically associated with immortalization of five independent human papilloma virus 16 (HPV16) E6-or E7-transformed HUCs. Cytogenetic analysis showed that the smallest common region of deletion was 3p14.1=14.2. Fluorescence in situ hybridization using a 3p13=14-specific yeast artificial chromosome (YAC) contig showed the precise localization of the breakpoints to be in 3p13 and 3p14.2, thus defining the smallest common overlap of 3p deletions in HPV16 E6-or E7-immortalized HUCs. These results suggest the presence in this region of genes involved in the control of senescence in vitro and possibly tumorigenesis in vivo.
📜 SIMILAR VOLUMES
Roentgenographically occult bronchogenic squamous cell carcinomas are early lung cancers that localize mainly within the bronchial wall and are thought to be a good model for elucidating chromosomal alterations during lung cancer progression. In this study, we analyzed allelic losses on chromosome r
## Abstract To study the possible relationships between origin activities and cellular processes leading to malignancy, we used an isogenic system of human embryo lung fibroblast cells WI38 and a SV40‐transformed variant, WI38 VA13 2RA (WI38(SV40)). We found that the activities of all initiation si
## Abstract Activity of Janus kinase 2 (JAK2) in the JAK2/STAT5 signaling pathway is critically controlled by suppressor of cytokine signaling‐1 (SOCS‐1). We have previously shown that __SOCS‐1__ is biallelically mutated in the primary mediastinal B‐cell lymphoma (PMBL) cell line MedB‐1, resulting